Type III systemic allergic reaction to natalizumab.
Leussink
Verena I
VI
Lehmann
Helmar C
HC
Hartung
Hans-Peter
HP
Gold
Ralf
R
Kieseier
Bernd C
BC
D000328:Adult; D000906:Antibodies / Q000009:adverse effects; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000276:immunology* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D003875:Drug Eruptions / Q000145:classification / Q000276:immunology / Q000473:pathology; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000145:classification* / Q000276:immunology* / Q000473:pathology; D000069442:Natalizumab
D000906:Antibodies; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab